Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Metabolic regulators Nampt and Sirt6 serially participate in the macrophage interferon antiviral cascade

Dantoft, Widad, Robertson, Kevin A, Watkins, W John ORCID: https://orcid.org/0000-0003-3262-6588, Strobl, Brigit and Ghazal, Peter ORCID: https://orcid.org/0000-0003-0035-2228 2019. Metabolic regulators Nampt and Sirt6 serially participate in the macrophage interferon antiviral cascade. Frontiers in Microbiology 10.3389/fmicb.2019.00355

[thumbnail of Metabolic regulators Nampt and Sirt6 FRONTIERS Dantoft Ghazal.pdf]
Preview
PDF - Accepted Post-Print Version
Download (489kB) | Preview

Abstract

Molecular determinants underlying interferon (IFN)-macrophage biology can help delineate enzyme systems, pathways and mechanisms for enabling host-directed therapeutic approaches against infection. Notably, while the IFN antiviral response is known to be directly coupled to mevalonate-sterol biosynthesis pathway mechanistic insight for providing host pathway-therapeutic targets, remain incomplete. Here, we show that Nampt and Sirt6 are coordinately regulated upon immune activation of macrophages and contribute to the IFN-sterol antiviral response. In silico analysis of the Nampt and Sirt6 promoter regions identified multiple core immune gene-regulatory transcription factor sites, including Stat1, implicating a molecular link to IFN control. Experimentally, we show using a range of genetically IFN-defective macrophages that the expression of Nampt is stringently regulated by the Jak/Stat-pathway while Sirt6 activation is temporally displaced in a partial IFN-dependent manner. We further show that pharmacological inhibition of Nampt and small interfering RNA (siRNA)-mediated inhibition of Nampt and Sirt6 promotes viral growth of cytomegalovirus in both fibroblasts and macrophages. Our results support the notion of pharmacologically exploiting immune regulated enzyme systems of macrophages for use as an adjuvant-based therapy for augmenting host protective pathway responses to infection.

Item Type: Article
Status: Published
Schools: Medicine
Publisher: Frontiers Media
ISSN: 1664-302X
Related URLs:
Date of First Compliant Deposit: 26 February 2019
Date of Acceptance: 11 February 2019
Last Modified: 26 Dec 2023 15:28
URI: https://orca.cardiff.ac.uk/id/eprint/119856

Citation Data

Cited 15 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics